As of August 04, 2026, Skye Bioscience's top three insider holders are Andrew J. Schwab (Director, 8.17Mn shares), Partners Vii, Llc 5Am (TenPercentOwner, 8.17Mn shares), Punit Dhillon (Chief Executive Officer, 2.34Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Punit Dhillon | Chief Executive Officer | 0 | 2,335,721 | 15 Nov, 2022 |
| Andrew J. Schwab | - | 0 | 8,167,206 | 13 Sep, 2024 |
| Paul A. Grayson | - | 259,701 | 0 | 19 Nov, 2024 |
| Partners Vii, Llc 5Am | - | 0 | 8,167,206 | 13 Sep, 2024 |
| Kaitlyn Arsenault | Chief Financial Officer | 166,342 | 0 | 19 Nov, 2024 |
| Sukhwinder Singh Rai | - | 0 | 95,718 | 15 Nov, 2022 |
| Tuan Tu Diep | Chief Development Officer | 82,259 | 0 | 19 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Punit Dhillon | Stock Option (Right to Buy) | A | 250,000 | - | 250,000 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 17,004 | - | 17,004 | D | A |
| 31 Mar, 2026 | Karen L. Smith | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 31 Mar, 2026 | Annalisa Jenkins | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 31 Mar, 2026 | Deborah H. Charych | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 31 Mar, 2026 | Tuan Tu Diep | Stock Option (Right to Buy) | A | 150,000 | - | 150,000 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 17,004 | - | 17,004 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 17,004 | - | 17,004 | D | A |
| 31 Mar, 2026 | Andrew J. Schwab | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 31 Mar, 2026 | Paul A. Grayson | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | D | 17,004 | - | 0 | D | D |
| 31 Mar, 2026 | Punit Dhillon | Stock Option (Right to Buy) | D | 250,000 | - | 0 | D | D |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | D | 17,004 | - | 0 | D | D |
| 31 Mar, 2026 | Tuan Tu Diep | Stock Option (Right to Buy) | D | 150,000 | - | 0 | D | D |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | D | 17,004 | - | 0 | D | D |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 75,000 | - | 75,000 | D | A |
| 31 Mar, 2026 | Punit Dhillon | Stock Option (Right to Buy) | A | 36,000 | - | 36,000 | D | A |
| 31 Mar, 2026 | Tuan Tu Diep | Stock Option (Right to Buy) | A | 9,194 | - | 9,194 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 75,000 | - | 75,000 | D | A |
| 31 Mar, 2026 | Christopher Twitty | Stock Option (Right to Buy) | A | 75,000 | - | 75,000 | D | A |